Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

489 results found

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

Restoring inhibitory control in the stressed amygdala


Grant type
Capacity building grants
Area of Research
Mental Health
Competition
Rising Stars Trainee Awards
Province
Ontario
Start Date
2026

Next Gen Award in Parkinson’s Disease Research

Investigating the role of EPG5 in Parkinson’s Disease pathogenesis


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Rising Stars Trainee Awards
Province
British Columbia
Start Date
2026

Characterization of Glutamatergic Premotor Spinal V3 Interneurons in a SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive disease that destroys the motor neurons needed for movement, speech, and breathing, but new research shows that other spinal cord cells called interneurons may be affected even earlier.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Rising Stars Trainee Awards
Province
Nova Scotia
Start Date
2026

Dr. Hubert van Tol Travel Fellowship

Sofia Gentile, a Master’s Student at University of Toronto, is investigating the role of immune cell activation in a rare and fatal neurodegenerative disease called progressive supranuclear palsy.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Rising Stars Trainee Awards
Province
Ontario
Start Date
2026

Rising Star Award in Mental Health Research, in memory of Vivian Distler

Personalized Modeling and Optimization of Transcranial Temporal Interference Stimulation in Major Depressive Disorder


Grant type
Capacity building grants
Area of Research
Mental Health
Competition
Rising Stars Trainee Awards
Province
Ontario
Start Date
2026

Targeting Cryptic Exon Inclusion to Modify the G3BP1 Interactome in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD) are devastating diseases in which a protein called TDP-43 ends up in the wrong part of the cell, disrupting its normal role in managing RNA.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Rising Stars Trainee Awards
Province
Québec
Start Date
2026

Therapeutic Targeting of GDF15 to Treat Anxiety in Diabetes


Area of Research
Mental Health
Competition
2025 End Diabetes Award (Mental Health Pool)
Province
Ontario
Start Date
2026

DIgital markers of Social Cognition for diagnosis & pRognosis in Neurodegeneration (DISCeRN)

Impairments in social cognition (SC), such as difficulties in understanding emotions, social cues, and maintaining meaningful interactions, are key contributors to the loss of social inclusion and quality of life in individuals with neurodegenerative diseases (ND).


Area of Research
Neurodegeneration
Competition
EU Joint Programme – Neurodegenerative Disease Research (JPND)
Province
Québec
Start Date
2026

Identification of novel ALS targets and development of non-invasive nanodiscs for ASO delivery

Amyotrophic Lateral Sclerosis (ALS) can result from many different mutations in the same gene, making mutation-specific treatments challenging.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Rising Stars Trainee Awards
Province
Ontario
Start Date
2026

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

The Role of Brain Endocannabinoid Metabolism in Social Anxiety Disorder and Social Stress


Grant type
Capacity building grants
Area of Research
Mental Health
Competition
Rising Stars Trainee Awards
Province
Ontario
Start Date
2026